Press Releases
LONG BEACH, Calif., Nov. 6, 2019 /PRNewswire/ -- The Spine Ce
Read more...6 November 2019
MARLBOROUGH, Mass., Nov. 6, 2019 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) announced the pricing of a public offering of €900,000,000 aggregate principal amount of its 0.625% notes due 2027, under the Company's shelf registration statement. The Company expects to receive the net offering proceeds upon closing on
Read more...NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of Ohio on behalf of all investors that purchased ViewRay, Inc. (N
Read more...6 November 2019
CUPERTINO, Calif., Nov. 6, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it will host a key opinion leader (KOL) conference call and live webcast to discuss the
Read more...6 November 2019
HOLLISTON, Mass., Nov. 6, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing next-generation esophageal implants, announced today that it will report its financial results for the three and nine months ended September 30, 2019 in a press release that will be issued pre-market on
Read more...6 November 2019
MONMOUTH JUNCTION, N.J., Nov. 6, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its
Read more...GATINEAU, Quebec, Nov. 6, 2019 /PRNewswire/ -- The Alliance for Safe Biologic Medicines (ASBM) today released an abstract from a forthcoming white paper that provides a comprehensive overview of the evolution of the European biosimilars market. The
Read more...6 November 2019
IRVINE, Calif., Nov. 6, 2019 /PRNewswire/ -- Inari Medical, Inc. today announced the presentation of early outcomes from the ClotTriever Outcomes Registry ("CLOUT") using the ClotTriever Mechanical Thrombectomy System for treatment of acute and chronic lower extremity deep vein thrombosis ("DVT"). Initial results for the first 50 patients were presented by prin
Read more...6 November 2019
NEW YORK and SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a bi
Read more...VANCOUVER, Nov. 6, 2019 /PRNewswire/ - CRH Medical Corporation (the "Company") (TSX: CRH) (NYSE American: CRHM), announces that it has received approval from the Toronto Stock Exchange ("TSX") of its Notice of Intention to renew its existing Normal Course Issuer Bid (the "Bid").Pursuant to the Bid, the Company may purchase for canc
Read more...